Ganciclovir

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Cymevan; Cymeven; Cymevene; Cytovene (Roche); Vitrasert
  • INDICATIONS: Cytomegalovirus retinitis in immunocompromised patients
  • CLASS: Antiviral, Guanine nucleoside analog
  • HALF-LIFE: 2.5–3.6 hours
GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA

See full prescribing information for complete boxed warning.

Our database has 44 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.


Page last updated 11/18/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top